- Corporate Officers - G
- Gadicke Ansbert
Insider Trading History of Gadicke Ansbert
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gadicke Ansbert since 2006.
This trader's CIK number is 1134655.
At the time of last reporting, Gadicke Ansbert was the Director of Tcr2 Therapeutics Inc.. (stock ticker symbol TCRR).
Also see all insider trading activities at Tcr2 Therapeutics Inc..
Note that in the past
GADICKE ANSBERT also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Pharmasset Inc (VRUS) by Gadicke Ansbert
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | VRUS | 0 | $0 | 666,296 | $13,644,920 | 0 | $0 |
| 2007 | VRUS | 277,777 | $2,499,993 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Omrix Biopharmaceuticals, Inc. (OMRI) by Gadicke Ansbert
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | OMRI | 0 | $0 | 29,320 | $582,004 | 0 | $0 |
Yearly summary of insider trading at Cullinan Oncology, Inc. (CGEM) by Gadicke Ansbert
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | CGEM | 300,000 | $6,300,000 | 302,396 | $8,850,166 | 0 | $0 |
Yearly summary of insider trading at Repare Therapeutics Inc. (RPTX) by Gadicke Ansbert
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | RPTX | 0 | $0 | 979,482 | $29,147,117 | 0 | $0 |
| 2020 | RPTX | 500,000 | $10,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Epizyme, Inc. (EPZM) by Gadicke Ansbert
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | EPZM | 0 | $0 | 466,666 | $13,649,980 | 0 | $0 |
Yearly summary of insider trading at Oncorus, Inc. (ONCR) by Gadicke Ansbert
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | ONCR | 325,000 | $4,875,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Somaxon Pharmaceuticals, Inc. (SOMX) by Gadicke Ansbert
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | SOMX | 0 | $0 | 2,545,254 | $766,408 | 0 | $0 |
Yearly summary of insider trading at Aratana Therapeutics, Inc. (PETX) by Gadicke Ansbert
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | PETX | 0 | $0 | 26,713 | $538,534 | 0 | $0 |
Yearly summary of insider trading at Tcr2 Therapeutics Inc. (TCRR) by Gadicke Ansbert
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | TCRR | 0 | $0 | 70,170 | $131,919 | 0 | $0 |
| 2019 | TCRR | 1,373,333 | $20,599,995 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Pacira Biosciences, Inc. (PCRX) by Gadicke Ansbert
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | PCRX | 0 | $0 | 500,000 | $13,930,000 | 0 | $0 |
| 2011 | PCRX | 997,252 | $6,749,995 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Verastem, Inc. (VSTM) by Gadicke Ansbert
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | VSTM | 100,000 | $1,000,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 11 companies by Gadicke Ansbert:
1. Pharmasset Inc (VRUS)
2. Omrix Biopharmaceuticals, Inc. (OMRI)
3. Cullinan Oncology, Inc. (CGEM)
4. Repare Therapeutics Inc. (RPTX)
5. Epizyme, Inc. (EPZM)
6. Oncorus, Inc. (ONCR)
7. Somaxon Pharmaceuticals, Inc. (SOMX)
8. Aratana Therapeutics, Inc. (PETX)
9. Tcr2 Therapeutics Inc. (TCRR)
10. Pacira Biosciences, Inc. (PCRX)
11. Verastem, Inc. (VSTM)
Table 1. Insider trading of Pharmasset Inc (VRUS) by Gadicke Ansbert
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-06-19 | VRUS | Sale | 155,800 | 19.93 | 3,105,717 |
| 2008-06-17 | VRUS | Sale | 101,900 | 20.18 | 2,056,545 |
| 2008-06-16 | VRUS | Sale | 281,149 | 20.31 | 5,709,855 |
| 2008-06-16 | VRUS | Sale | 18,979 | 19.19 | 364,169 |
| 2008-06-13 | VRUS | Sale | 1,321 | 19.00 | 25,099 |
| 2008-06-10 | VRUS | Sale | 5,175 | 19.06 | 98,625 |
| 2008-06-05 | VRUS | Sale | 10,083 | 19.15 | 193,049 |
| 2008-02-07 | VRUS | Sale | 36,664 | 23.02 | 844,005 |
| 2008-02-08 | VRUS | Sale | 27,925 | 21.36 | 596,478 |
| 2008-02-04 | VRUS | Sale | 27,300 | 23.86 | 651,378 |
| 2007-05-02 | VRUS | Buy | 277,777 | 9.00 | 2,499,993 |
Table 2. Insider trading of Omrix Biopharmaceuticals, Inc. (OMRI) by Gadicke Ansbert
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-10-23 | OMRI | Sale | 14,225 | 19.95 | 283,788 |
| 2006-10-24 | OMRI | Sale | 15,095 | 19.76 | 298,216 |
Table 3. Insider trading of Cullinan Oncology, Inc. (CGEM) by Gadicke Ansbert
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-09-16 | CGEM | Sale | 3,556 | 29.06 | 103,337 |
| 2021-09-14 | CGEM | Sale | 8,088 | 29.17 | 235,926 |
| 2021-09-15 | CGEM | Sale | 7,313 | 29.16 | 213,247 |
| 2021-09-09 | CGEM | Sale | 15,625 | 29.35 | 458,593 |
| 2021-09-10 | CGEM | Sale | 6,751 | 29.04 | 196,049 |
| 2021-09-13 | CGEM | Sale | 4,092 | 29.10 | 119,077 |
| 2021-09-03 | CGEM | Sale | 14,491 | 29.60 | 428,933 |
| 2021-09-08 | CGEM | Sale | 12,341 | 29.11 | 359,246 |
| 2021-09-07 | CGEM | Sale | 28,532 | 29.04 | 828,569 |
| 2021-09-01 | CGEM | Sale | 6,504 | 29.47 | 191,672 |
| 2021-09-02 | CGEM | Sale | 17,935 | 29.46 | 528,365 |
| 2021-08-31 | CGEM | Sale | 3,230 | 29.79 | 96,205 |
| 2021-08-27 | CGEM | Sale | 15,203 | 29.09 | 442,255 |
| 2021-08-30 | CGEM | Sale | 35,286 | 29.30 | 1,033,879 |
| 2021-08-25 | CGEM | Sale | 1,950 | 29.09 | 56,725 |
| 2021-08-24 | CGEM | Sale | 57,907 | 29.48 | 1,707,098 |
| 2021-08-23 | CGEM | Sale | 60,735 | 29.11 | 1,767,995 |
| 2021-08-11 | CGEM | Sale | 2,857 | 29.05 | 82,995 |
| 2021-01-12 | CGEM | Buy | 300,000 | 21.00 | 6,300,000 |
Table 4. Insider trading of Repare Therapeutics Inc. (RPTX) by Gadicke Ansbert
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-07-12 | RPTX | Sale | 58,012 | 33.84 | 1,963,126 |
| 2021-07-09 | RPTX | Sale | 4,067 | 33.06 | 134,455 |
| 2021-06-21 | RPTX | Sale | 37,588 | 34.22 | 1,286,073 |
| 2021-06-22 | RPTX | Sale | 3,800 | 33.73 | 128,155 |
| 2021-06-23 | RPTX | Sale | 1,410 | 32.98 | 46,501 |
| 2021-06-18 | RPTX | Sale | 9,000 | 33.74 | 303,705 |
| 2021-06-17 | RPTX | Sale | 32,518 | 33.95 | 1,103,986 |
| 2021-06-08 | RPTX | Sale | 26,200 | 33.10 | 867,350 |
| 2021-06-09 | RPTX | Sale | 35,230 | 34.60 | 1,219,134 |
| 2021-06-02 | RPTX | Sale | 6,215 | 32.12 | 199,656 |
| 2021-05-28 | RPTX | Sale | 16,742 | 32.67 | 546,961 |
| 2021-06-01 | RPTX | Sale | 15,141 | 32.50 | 492,082 |
| 2021-05-25 | RPTX | Sale | 6,572 | 33.23 | 218,387 |
| 2021-05-26 | RPTX | Sale | 24,036 | 32.88 | 790,183 |
| 2021-05-27 | RPTX | Sale | 7,951 | 32.98 | 262,263 |
| 2021-03-12 | RPTX | Sale | 695,000 | 28.18 | 19,585,100 |
| 2020-06-23 | RPTX | Buy | 500,000 | 20.00 | 10,000,000 |
Table 5. Insider trading of Epizyme, Inc. (EPZM) by Gadicke Ansbert
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-02-10 | EPZM | Sale | 466,666 | 29.25 | 13,649,980 |
Table 6. Insider trading of Oncorus, Inc. (ONCR) by Gadicke Ansbert
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-10-06 | ONCR | Buy | 325,000 | 15.00 | 4,875,000 |
Table 7. Insider trading of Somaxon Pharmaceuticals, Inc. (SOMX) by Gadicke Ansbert
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-07-09 | SOMX | Sale | 1,624,574 | .31 | 498,744 |
| 2012-07-06 | SOMX | Sale | 671,217 | .29 | 195,324 |
| 2012-07-02 | SOMX | Sale | 80,348 | .29 | 23,300 |
| 2012-07-03 | SOMX | Sale | 98,210 | .29 | 28,480 |
| 2012-06-28 | SOMX | Sale | 19,500 | .29 | 5,655 |
| 2012-06-19 | SOMX | Sale | 12,000 | .29 | 3,479 |
| 2012-06-15 | SOMX | Sale | 1,450 | .29 | 420 |
| 2012-06-06 | SOMX | Sale | 8,400 | .29 | 2,436 |
| 2012-06-05 | SOMX | Sale | 29,555 | .29 | 8,570 |
Table 8. Insider trading of Aratana Therapeutics, Inc. (PETX) by Gadicke Ansbert
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-03-07 | PETX | Sale | 26,713 | 20.16 | 538,534 |
Table 9. Insider trading of Tcr2 Therapeutics Inc. (TCRR) by Gadicke Ansbert
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-05-22 | TCRR | Sale | 70,170 | 1.88 | 131,919 |
| 2019-02-19 | TCRR | Buy | 1,373,333 | 15.00 | 20,599,995 |
Table 10. Insider trading of Pacira Biosciences, Inc. (PCRX) by Gadicke Ansbert
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-03-11 | PCRX | Sale | 500,000 | 27.86 | 13,930,000 |
| 2011-11-21 | PCRX | Buy | 461,538 | 6.50 | 2,999,997 |
| 2012-02-08 | PCRX | Buy | 535,714 | 7.00 | 3,749,998 |
Table 11. Insider trading of Verastem, Inc. (VSTM) by Gadicke Ansbert
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-02-01 | VSTM | Buy | 100,000 | 10.00 | 1,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Gadicke Ansbert
(Director of Tcr2 Therapeutics Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.